Salvatore Salamone


Salvatore Salamone is a scientist and researcher within diagnostic medicine and therapeutic drug monitoring. He is g responsible for the development of many of the major reagents used within psychiatric drug level monitoring. Salamone is the founder of Saladax Biomedical, Inc. His contributions to diagnostic medicine have been recognized through several local awards, includingthe Ben Franklin Innovation Award and the New Jersey Inventors Hall of Fame in 2016. Salamone has 70 FDA-approved products and more than 200 instrument applications. He is the editor of a textbook on benzodiazapines and is also the holder of 41 issued US patents.

Education

Salamone earned two bachelor’s degrees from Villanova University, a master’s and a PhD degree from Rutgers University and was a Science Engineering Research Council Post-Doctoral Fellow at the University of Oxford, UK.